Does Acyclovir Lose Effectiveness Over Time?
Acyclovir maintains effectiveness for treating herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections with prolonged use in most patients. Clinical studies show no significant decline in antiviral activity against susceptible strains, even after years of episodic or suppressive therapy. For example, daily suppressive dosing reduces HSV recurrence rates by 70-80% consistently over 1-5 years.[1][2]
Why Doesn't Tolerance Develop Like with Some Antibiotics?
Acyclovir works by inhibiting viral DNA polymerase directly, without relying on host immune modulation or bacterial mutation pressures that cause resistance in antibiotics. HSV and VZV lack the rapid evolutionary adaptability of bacteria, so efficacy holds unless pre-existing resistant mutants emerge.[3]
When Does Resistance Happen and How Common Is It?
Resistance occurs in 5-10% of immunocompromised patients (e.g., HIV, transplant recipients) after prolonged exposure, often due to thymidine kinase gene mutations in the virus. In healthy individuals, rates stay below 1% even with years of suppressive therapy. Risk rises with higher doses or longer durations in vulnerable groups.[1][4]
What Happens If Resistance Develops?
Susceptible viruses respond to standard doses (e.g., 400mg 3x/day for suppression). Resistant cases show breakthrough lesions; switch to alternatives like foscarnet or cidofovir, which target different viral enzymes. Lab testing confirms resistance via plaque assays or genotyping.[3][5]
How Do Doctors Manage Long-Term Use?
Guidelines recommend monitoring for resistance in high-risk patients via clinical response and viral swabs. Dose adjustments or therapy breaks aren't typically needed for efficacy in immunocompetent users. Combine with immune boosters if recurrences persist.[2][6]
Alternatives If Acyclovir Stops Working
Valacyclovir (prodrug of acyclovir) or famciclovir offer similar profiles with potentially better bioavailability, used interchangeably for long-term suppression. No patents limit generics; all are low-cost.[1]
[1]: CDC Herpes Treatment Guidelines
[2]: NEJM: Long-term Suppressive Acyclovir
[3]: Antiviral Resistance Mechanisms Review
[4]: Resistance in Immunocompromised Patients
[5]: IDSA Antiviral Guidelines
[6]: WHO HSV Management